Search company, investor...

Revotar Biopharmaceuticals

revotar.de

Founded Year

2000

Stage

Unattributed VC | Alive

About Revotar Biopharmaceuticals

Revotar Biopharmaceuticals develops anti-inflammatory drugs for inflammatory indications such as psoriasis, acute lung injury (ALI), and chronic obstructive pulmonary disease (COPD). The company was founded in 2000 and is based in Hennigsdorf, Germany.

Headquarters Location

Neuendorfstraße 24 A

Hennigsdorf, 16761,

Germany

+49-3302-202-5010

Missing: Revotar Biopharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Revotar Biopharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Revotar Biopharmaceuticals Patents

Revotar Biopharmaceuticals has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/23/2011

6/11/2013

Clusters of differentiation, Prodrugs, Immunology, Monoclonal antibodies, Immunosuppressants

Grant

Application Date

2/23/2011

Grant Date

6/11/2013

Title

Related Topics

Clusters of differentiation, Prodrugs, Immunology, Monoclonal antibodies, Immunosuppressants

Status

Grant

Revotar Biopharmaceuticals Frequently Asked Questions (FAQ)

  • When was Revotar Biopharmaceuticals founded?

    Revotar Biopharmaceuticals was founded in 2000.

  • Where is Revotar Biopharmaceuticals's headquarters?

    Revotar Biopharmaceuticals's headquarters is located at Neuendorfstraße 24 A, Hennigsdorf.

  • What is Revotar Biopharmaceuticals's latest funding round?

    Revotar Biopharmaceuticals's latest funding round is Unattributed VC.

  • Who are the investors of Revotar Biopharmaceuticals?

    Investors of Revotar Biopharmaceuticals include Saxony Ministry of Economic Affairs, bmp media investors, Brandenburg Ministry of Economics, Gradus Venturenvestment Management, MVC Unternehmensbeteiligungsgesellschaft mbH and 6 more.

  • Who are Revotar Biopharmaceuticals's competitors?

    Competitors of Revotar Biopharmaceuticals include Lung Therapeutics and 2 more.

Compare Revotar Biopharmaceuticals to Competitors

P
Pneuma Pharmaceuticals

Pneuma Pharmaceuticals is a private research pharmaceutical company that is developing therapeutic uses for calfactant beyond treatment for respiratory distress syndrome. Pneuma is conducting an international multicenter phase 3 pivotal trial of calfactant for Acute Respiratory Distress Syndrome/Acute Lung Injury in adult patients, which is on track to be completed in 2010. Pneuma Pharmaceuticals has been a member of the incubator since 2008.

Lung Therapeutics Logo
Lung Therapeutics

Lung Therapeutics pursues treatments for underserved, life-threatening lung conditions. Its therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural Effusion bring hope to patients whose only treatment options may be invasive surgery or costly and ineffective drugs. The company aims to create better pharmaceutical treatment options for IPF, LPE, and other underserved lung conditions. The company was founded in 2013 and is based in Austin, Texas.

A
Anthera Pharmaceuticals

Anthera Pharmaceuticals is a pharmaceutical development company focused on the development and advancement of promising clinical products for the treatment of serious inflammatory diseases. Anthera's lead products have the potential to address a variety of inflammatory diseases including: acute lung injury, acute respiratory distress syndrome, acute chest syndrome, acute coronary syndrome, atherosclerosis, chronic obstructive pulmonary disease and psoriasis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.